Ohara Pharmaceuticals invests in healthcare companies, including digital health and fintech solutions for healthcare providers. They participated in Helium Health's Series B round, which will be used to grow the company's software tools and financing solutions, with a specific emphasis on HeliumCredit, the fintech offering of the startup.
Auto-discovered — editorial review pending